CFTR and cystic fibrosis: In recent years, new treatments and clinical trials have focused on CFTR modulator therapies and alternative antibacterial approaches, such as nitric oxide (NO) delivery, to combat infections from CF-related bacteria like Pseudomonas aeruginosa and Staphylococcus aureus [6].